Healthcare
Live Price
Offline$0.1689
+0.00% today
1Y Change
-40.76%
Window
Jun 25, 2025 โ Jun 19, 2026
Coverage: 236 bars ยท Jun 25, 2025 โ Jun 19, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Conavi Medical Corp. (CNVIF) is a Healthcare stock with a market cap of $90.00M and listed on OTC. The stock last traded around $0.17 and down 40.8% across the available one-year price window (Jun 25, 2025 โ Jun 19, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS 0.0%, free cash flow 0.0% with operating margin 27.4% and ROIC 79.0%. Valuation is more restrained than many high-expectation growth names at P/E 13.4 and price/sales 5.3. Stock Foundry combines CNVIF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +7.6% peer median
Operating Margin
Above sector median
+27.4% vs +19.4% peer median
P/E
Below sector median
13.4 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 29, 2026, but the surprise data is still limited.
The setup is mixed rather than one-directional
Revenue is 0.0% and EPS is 0.0%, while operating margin sits near 27.4%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +3.9% over the next 5 trading days and finished higher after 2 of those reports.
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 29, 2026 | โ | +11.3% | -5.4% | โ |
2026 Feb 26, 2026 | โ | +0.0% | +11.4% | +4.4% |
2025 Dec 29, 2025 | -125.0% | +4.2% | +5.7% | -2.4% |
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CNVIF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CNVIF Max Drawdown
-67.02%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for CNVIF and SPY.
Company Overview
Conavi Medical Corp.
OTC
Conavi Medical Corp. is a medical technology company specializing in designing, manufacturing, and marketing advanced imaging technologies. These solutions are primarily developed to guide common minimally invasive cardiovascular procedures, enhancing the precision and outcomes of such interventions. By integrating imaging expertise, Conavi Medical Corp. provides critical tools that support healthcare professionals in cardiovascular diagnostics and interventions. The company plays a significant role in the health care equipment sector, contributing to the advancement of less invasive treatment options in cardiovascular medicine. Its products facilitate improved visualization, which is essential for navigating the complexities of cardiovascular anatomy during procedures. Conavi Medical Corp. thus occupies an important niche in the intersection of medical imaging and interventional cardiology, supporting better patient care through innovative imaging technology.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.